CORRELATES OF ADHERENCE TO IMMUNOSUPPRESSANT MEDICATIONS IN COMMUNITY DWELLING SOLID ORGAN TRANSPLANT RECIPIENTS
Author(s)
Sankaranarayanan J1, Collier DS1, Furasek AN1, Smith LM1, McCartan M2, Langnas AN11University of Nebraska Medical Center, Omaha, NE, USA, 2The Nebraska Medical Center, Omaha, NE, USA
OBJECTIVES: To address limited data in Midwest solid organ transplant recipient (SOTR) populations we determined the patient’s demographic and medical characteristics associated with self-reported immunosuppressant (IST) adherence on a 4-item measure (ITAS). METHODS: Cross-sectional survey-data (patient: residence zip code, education, marital status, annual income, health-status, insurance coverage; condition: comorbidities; therapy: total number of medications other than IST; and ITAS) was received from >/=19 year old adult SOTR of an academic transplant center located in mid west US. For this retrospective study, survey-data were merged with other patient (age, race, gender); condition (transplant-type, years since last transplant); IST-drug therapy-data from the center’s database. Multivariate stepwise logistic regression was used to identify significant patient characteristics for the dependent variable of being “adherent” (ITAS score =12) compared with being “nonadherent” (ITAS score <12). RESULTS: Respondents had either kidney (269 [48.5%]), liver (263[47.2%]), or other (25[4.5%]) transplant. Other respondent characteristics were: age (mean 56 years), male (55.5%), white (90.1%), married (69.9%), less than $55,000 annual income (57.3%), metro-resident (59%), Medicare-insurance (47.8%), excellent to good health status (77.5%), years since last transplant (mean 7.53 +/- SD 5.87). The SOTRs were on different IST regimens (Tacrolimus based combination IST drugs, 39.2%, Tacrolimus, 22.3%, Cyclosporine, 20.7%, Cyclosporine combinations, 9%, Other, 8.8%). More than half (320/557; 57.5%) of the SOTRs self-reported “adherence”. In a multivariate stepwise logistic regression model including all patient characteristics; age less than 65 years (p=0.0002), living in non metro rural areas (p=0.041), and greater than or equal to 6 co-morbidities (p=0.0040) significantly decreased the likelihood of adherence compared with nonadherence. In the same model, however, Tacrolimus based combination-IST rather than Tacrolimus alone (p = 0.019), significantly increased the likelihood of adherence compared with non-adherence. CONCLUSIONS: Our study identified patient, condition, and IST-therapy correlates of IST-adherence which providers may consider to deliver IST-adherence improving interventions.
Conference/Value in Health Info
2010-05, ISPOR 2010, Atlanta, GA, USA
Value in Health, Vol. 13, No. 3 (May 2010)
Code
PSY36
Topic
Patient-Centered Research
Topic Subcategory
Adherence, Persistence, & Compliance
Disease
Diabetes/Endocrine/Metabolic Disorders, Multiple Diseases